Application 219008

Type
NDA
Sponsor
JANSSEN BIOTECH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAZCLUZELAZERTINIB MESYLATETABLET;ORALEQ 80MG BASEYesNo
002LAZCLUZELAZERTINIB MESYLATETABLET;ORALEQ 240MG BASEYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85841SUPPL 2026-05-05
85817SUPPL 2026-05-04
84140SUPPL 2025-11-12
84130SUPPL 2025-11-10
83108SUPPL 2025-08-18
79628ORIG 2024-09-16
79450ORIG 2024-08-20
79439ORIG 2024-08-20